NDAORALTABLET
Approved
Sep 2010
Lifecycle
Peak
Competitive Pressure
8/100
Mechanism of Action
ovulation.
Indications (8)
symptoms of premenstrual dysphoric disorder (PMDD) in females of reproductive potentialmoderate acne vulgaris in females of reproductive potential at least 14 years of agefemales of reproductive potentialto raise folate levels for the purpose of reducing the risk of a neural tube defect in a pregnancy conceived while taking the productshortly after discontinuing the productanxietypregnancymoderate acne for females of reproductive potential at least 14 years old only if the patient desires an oral contraceptive for birth control
Loss of Exclusivity
LOE Date
Jul 17, 2030
53 months away
Patent Expiry
Jul 17, 2030